Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 6,246 shares at $69.53 ($434K) on 2020-03-06, disclosed to the SEC on 2020-03-10.
Open-market sale of $434k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.53 | 3,123 | $217K | 50.0% |
| 2 | $69.53 | 3,123 | $217K | 50.0% |
| Total | $69.53 avg | 6,246 | $434K | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |